Harvard Bioscience Inc. (HBIO)
NASDAQ: HBIO
· Real-Time Price · USD
0.49
-0.03 (-5.81%)
At close: Aug 29, 2025, 3:58 PM
-5.81% (1D)
| Bid | 0.49 |
| Market Cap | 22.04M |
| Revenue (ttm) | 88.75M |
| Net Income (ttm) | -57.41M |
| EPS (ttm) | -1.29 |
| PE Ratio (ttm) | -0.38 |
| Forward PE | 3.56 |
| Analyst | Hold |
| Ask | 0.51 |
| Volume | 325,989 |
| Avg. Volume (20D) | 1,863,238 |
| Open | 0.53 |
| Previous Close | 0.52 |
| Day's Range | 0.49 - 0.53 |
| 52-Week Range | 0.28 - 3.14 |
| Beta | 1.55 |
About HBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Harvard Bioscience Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+12.07%
Harvard Bioscience shares are trading higher after...
Unlock content with
Pro Subscription
4 months ago
+11.78%
Harvard Bioscience shares are trading higher after the company reported better-than-expected Q1 financial results.
